More recent studies have yielded additional support for our finding; DII is reported to be directly related to all markers of T2D risk, including fasting insulin, fasting glucose HbA1c, homeostasis model assessment index for insulin resistance (HOMA2-IR), and two-hour glucose levels [21]. This evidence concerns the gene INS and Insulin resistance.